Syndromic reverse transcriptase–polymerase chain reaction tests for respiratory infections were associated with lower health care resource utilization and costs, implicating potential for improved value in patient care.
Jason Yeaw, MPH
Advertisement
Articles by Jason Yeaw, MPH
Adherence to newly initiated biologic therapy for rheumatoid arthritis is important for long-term adherence.
Advertisement
Latest Updated Articles
Health Care Utilization and Cost of Diagnostic Testing for Respiratory InfectionsPublished: September 17th 2025 | Updated:
- Two-Year Adherence and Costs for Biologic Therapy for Rheumatoid Arthritis
Published: July 12th 2018 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Bringing Advanced Cancer Care Closer to Patients Improves Access, Equity: Kathy Oubre, MS
2
Real-World Data Support Dual Benefit of Biologic Therapy for Hidradenitis Suppurativa
3
How Health Systems, Industry Partnerships Advance Rare Disease Therapies: David Mitchell, PharmD, MBA
4
ERS Posters Showcase Nerandomilast Benefits in IPF, ILD
5
